Carlsmed Inc (CARL)

Currency in USD
17.42
+0.20(+1.16%)
Closed·
17.45+0.03(+0.17%)
·
CARL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
16.9118.25
52 wk Range
8.5019.15
Key Statistics
Prev. Close
17.42
Open
17.3
Day's Range
16.91-18.25
52 wk Range
8.5-19.15
Volume
261.69K
Average Volume (3m)
115.17K
1-Year Change
39.4716%
Book Value / Share
2.77
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CARL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
22.00
Upside
+26.29%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Carlsmed Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 22.00
(+26.29% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Needham
Buy22.00+26.29%17.00MaintainNov 11, 2026
Truist Securities
Buy23.00+32.03%20.00MaintainNov 11, 2026
BTIG
Buy26.00+49.25%24.00MaintainNov 11, 2026
Truist Securities
Buy20.00+14.81%18.00MaintainAug 06, 2026
Needham
Buy17.00-2.41%-New CoverageJul 01, 2026

Carlsmed Inc Earnings Call Summary for Q3/2026

  • Carlsmed posted Q3 2026 adjusted EPS loss of $0.34, beating estimates by $0.07; revenue surged 65% YoY to $21.6M despite shares falling 8.35%.
  • Company raised FY2026 revenue guidance to $78M-$80M from $74M-$78M, implying 56% growth; gross margin expanded to 77.3% from 75.9% prior year.
  • Q3 marked first quarter of positive operating leverage; adjusted EBITDA loss narrowed to $7.3M from $8.2M YoY as business scales efficiently.
  • Management highlighted new Medicare reimbursement effective Oct. 1, commercial launch of posterior bilateral procedure, and Corra cervical system rollout.
  • Trained surgeons grew 60%+ YoY while procedure volume rose 76%; cervical procedures reached 12% of sales, up from low-single-digit initial expectations.
Last Updated: 11/11/2026, 06:22 AM
Read Full Transcript

Earnings

Latest Release
Nov 10, 2026
EPS / Forecast
-0.34 / -0.41
Revenue / Forecast
21.6M / --
EPS Revisions
Last 90 days

CARL Income Statement

Compare CARL to Peers and Sector

Metrics to compare
CARL
Peers
Sector
Relationship
P/E Ratio
−11.9x−1.9x−0.2x
PEG Ratio
−0.23−0.260.00
Price/Book
6.3x2.4x2.6x
Price / LTM Sales
6.7x3.0x2.6x
Upside (Analyst Target)
26.3%170.8%76.9%
Fair Value Upside
Unlock−0.7%14.9%Unlock

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
3.40M12.40%59.03M
Other Institutional Investors
25.08M87.60%435.69M
Public Companies & Retail Investors
0.000.00%0.00
Total
28.48M100.00%494.72M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
B Capital Group Management, L.P.30.37%8,321,763144,549
B Capital Global Growth III, L.P.18.30%5,013,83987,090

People Also Watch

23.23
PRMB
-0.26%
252.73
ASND
-1.26%
41.99
TENB
-4.76%
137.42
SEZL
-6.09%

FAQ

What Is the Carlsmed (CARL) Stock Price Today?

The Carlsmed stock price today is 17.42 USD.

What Stock Exchange Does Carlsmed Trade On?

Carlsmed is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Carlsmed?

The stock symbol for Carlsmed is "CARL."

What Is the Carlsmed Market Cap?

As of today, Carlsmed market cap is 471.90M USD.

What Is Carlsmed's Earnings Per Share (TTM)?

The Carlsmed EPS (TTM) is -1.48.

From a Technical Analysis Perspective, Is CARL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Carlsmed Stock Split?

Carlsmed has split 0 times.

How Many Employees Does Carlsmed Have?

Carlsmed has 127 employees.

What is the current trading status of Carlsmed (CARL)?

As of Nov 21, 2026, Carlsmed (CARL) is trading at a price of 17.42 USD, with a previous close of 17.42 USD. The stock has fluctuated within a day range of 16.91 USD to 18.25 USD, while its 52-week range spans from 8.50 USD to 19.15 USD.

What Is Carlsmed (CARL) Price Target According to Analysts?

The average 12-month price target for Carlsmed is 22.00 USD, with a high estimate of 26 USD and a low estimate of 18 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +26.29% Upside potential.

What Is the CARL Premarket Price?

CARL's last pre-market stock price is 16.89 USD. The pre-market share volume is 230.00, and the stock has decreased by -0.33, or -1.92%.

What Is the CARL After Hours Price?

CARL's last after hours stock price is 17.45 USD, the stock has decreased by 0.03, or 0.17%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.